Skip to main content

Table 2 APOA5 and APOC3 polymorphism frequencies in patients with bulbar plaque present or absent.

From: Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene

A) Plaque present

Pat Num

APOC3 sstI rs5128

APOA5 1131T > C rs662799

APOA5 S19W rs3135506

 

101

    

76

    

90

GC

TC

  

36

 

TC

  

35

    

44

GC

TC

  

28

    

86

  

SW

 

63

GC

TC

  

4

GC

TC

  

87

GC

TC

  

20

GC

TC

  

45

GC

TC

  

71

 

TC

  

27

    

48

  

SW

 

37

GC

TC

  

52

    

38

  

SW

 

93

GC

TC

  

6

    

16

    

89

    

3

  

SW

 

91

GC

TC

SW

 

n

10

12

5

 

B) Plaque absent

Pat Num

APOC3 sstI rs5128

APOA5 1131T > C rs662799

APOA5 S19W rs3135506

 

46

    

100

    

40

    

72

  

WW

 

33

 

TC

  

62

GC

   

60

    

65

    

97

GC

   

21

GC

TC

  

73

    

102

    

5

  

SW

 

14

 

TC

  

50

  

SW

 

8

 

TC

  

95

    

61

 

TC

  

12

    

64

    

47

GC

   

85

 

TC

SW

 

94

    

11

    

1

    

53

    

25

    

98

    

34

GC

   

59

    

31

    

23

  

SW

 

74

 

TC

SW

 

70

  

SW

 

66

  

SW

 

n

5

7

7/1

 

C: Summary of APOA5 and APOC3 polymorphism fre quencies

APOC3 sstI

APOA5-1131T > C

APOA5 S19W

Plaque Present

Plaque Absent

GG

TT

SS

9

18

GG

TC

SS

2

4

GG

TT

SW

4

5

GG

TC

SW

0

2

GG

TT

WW

0

1

GC

TT

SS

0

4

GC

TC

SS

9

1

GC

TC

SW

1

0